Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Solesence (SLSN) Research & Development (2016 - 2025)

Historic Research & Development for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to $1.1 million.

  • Solesence's Research & Development rose 1154.64% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 1748.37%. This contributed to the annual value of $3.8 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Solesence's Research & Development stood at $1.1 million, which was up 1154.64% from $955000.0 recorded in Q2 2025.
  • In the past 5 years, Solesence's Research & Development ranged from a high of $1.1 million in Q4 2024 and a low of $499000.0 during Q1 2021
  • Moreover, its 5-year median value for Research & Development was $864000.0 (2024), whereas its average is $842052.6.
  • Data for Solesence's Research & Development shows a peak YoY increase of 5679.01% (in 2021) and a maximum YoY decrease of 5990.06% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Solesence's Research & Development stood at $565000.0 in 2021, then rose by 28.67% to $727000.0 in 2022, then rose by 7.98% to $785000.0 in 2023, then soared by 38.98% to $1.1 million in 2024, then decreased by 0.82% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $955000.0 for Q2 2025, and $1.0 million during Q1 2025.